STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow STE
STERIS plc (STE) Book value per share
STERIS plc's book value per share at the end of fiscal 2026 was 73.3×, up 9.23% from 67.1× in fiscal 2025. At the end of the quarter to 30 June 2026 it was 74.0×. Over the past ten years it has ranged from 18.1× (fiscal 2015) to 73.3× (fiscal 2026) — the current reading is the highest in ten years. STERIS plc ranks 3rd of 149 Medical Devices companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2026 | 73.3× | 9.23% |
| FY2025 | 67.1× | 4.97% |
| FY2024 | 63.9× | 4.70% |
| FY2023 | 61.1× | (9.02%) |
| FY2022 | 67.1× | 46.92% |
| FY2021 | 45.7× | 13.28% |
| FY2020 | 40.3× | 7.04% |
| FY2019 | 37.7× | (0.45%) |
| FY2018 | 37.8× | 15.09% |
| FY2017 | 32.9× | (23.52%) |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 74.0× | 0.95% |
| Mar 2026 | 73.3× | 0.41% |
| Dec 2025 | 73.0× | 2.28% |
| Sep 2025 | 71.4× | 0.75% |
| 42 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| BIO.B Bio-Rad Laboratories, Inc. compare | 268× |
| STE STERIS plc | 74.0× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 65.7× |
| PEN Penumbra, Inc. compare | 38.9× |
| GMED Globus Medical, Inc. compare | 35.3× |
| GEHC GE HealthCare Technologies Inc. compare | 24.3× |
| PHG Koninklijke Philips N.V. compare | 14.0× |
| DXCM DexCom, Inc. compare | 6.9× |
| SNN Smith & Nephew SNATS, Inc. compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on STE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement